期刊文献+

肺癌相关肿瘤标志物与支气管-肺感染的关系 被引量:1

The Relationship of Lung Cancer-related Tumor Makers with Bronchi-pulmonary Infection
下载PDF
导出
摘要 目的探讨相关肿瘤标志物(tum orm arker,TM s)对肺癌的诊断价值及与支气管-肺感染的关系。方法测定30例肺癌和195例支气管-肺感染病人血清癌胚抗原(CEA)、糖链抗原211(CA 211)、神经元特异性烯醇化酶(N SE)、糖链抗原199(CA 199)、肿瘤特异性生长因子(TSGF)水平,对临床资料进行分析。结果肿瘤组血清CEA、CA 211、CA 199、N SE均明显高于感染组(P<0.01),TSGF两组间无显著差异(P>0.05)。感染组TM s均值低于正常参考值,但有部分病例高于正常参考值。感染组感染控制后TM s无明显下降,死亡病例CA 211水平明显高于存活病例(P<0.01),血清CEA、CA 199、N SE水平在死亡病例与存活病例间无显著差异(P>0.05)。结论支气管-肺感染患者血清TM s无明显增高,对血清TM s增高的仍应注意排除肿瘤。 Objective To explore the utility of lung cancer-related tumor makers (TMs)in the diagnosis of lung cancer and the relationship between tumor makers and bronchi-pulmonary infection. Methods Serum levels of CEA,CA211 ,NSE,CA199 and TGSF were analyzed in 30 patients with lung cancer and in 195 cases with bronchi-pulmonary infection. Results The levels of CEA,CA211,CA199,NSE in lung cancer group were significantly higher than that of infection group(P〈0.01). There was no significant difference between the two groups in level of TGSF(P〉0.05). The average value of TMs was lower than the normal value in infection group,but in some cases the levels of TMs was higher than that of the normal value. In infection group,no significant decrease of TMs had been found after the control of infection,the serum level of CA211 was significantly higher in death cases than that of in survive patients (P〈0.01),there were no significant differences in levels of CEA,CA199,NSE between the two groups(P〉0.05). Conclusion The levels of TMs had no significantly increased in patients with bronchi-pulmonary infection.
出处 《临床肺科杂志》 2006年第1期12-13,共2页 Journal of Clinical Pulmonary Medicine
关键词 肿瘤标志物 感染 Tumor marker Infection
  • 相关文献

参考文献3

二级参考文献9

  • 1王凯.β-微球蛋白与肿瘤[J].国外医学肿瘤分册,1991,6:337-337.
  • 2Reinsber J. Different efficacy of various blocking reagents to eliminate interference by human anti-bodies with site immunoassay. Clinical biolchemistry. 1999; 29:145~148.
  • 3Hasholzner U,et al. Value of HAMA-determination in clnical practice-anoverview,Anticancer Research, 1997 ; 170: 3035~3058.
  • 41,曾小澜,麦羡霞,李新爱,等.恶性肿瘤患者血清TSGF测定及其应用价值的评估.中国癌症研究进展(4).暨南大学出版社,1998;256
  • 53,Gianfranco B,Pietro M,Armando P,et al.The soluble interleukin-2 receptor in lungcancer.Chest,1991;99(6):1433
  • 65,Ziegler J.Cancer and arthritis share underlying processes.Journal of national cancerinstitute,1998;90(11):802
  • 7高文斌,戚晓军,尹淑珍,刘伟,周红.血清恶性肿瘤生长因子检测在肝癌介入治疗中的意义[J].上海免疫学杂志,1998,18(2):126-126. 被引量:136
  • 8李春海.加强肿瘤生物学标志的研究和评价[J].中华检验医学杂志,2000,23(1):6-8. 被引量:101
  • 9黄学文,赵琪.人抗小鼠抗体对CA199检测的影响[J].临床检验杂志,2001,19(6):357-358. 被引量:1

共引文献37

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部